Phase II trial of palbociclib in recurrent RB-positive anaplastic oligodendroglioma: A Spanish group for research in neurooncology (GEINO) trial.

Authors

null

Juan Manuel Sepulveda-Sanchez

Hospital Universitario 12 de Octubre, Madrid, Spain

Juan Manuel Sepulveda-Sanchez , Miguel J. Gil Gil , Miriam Alonso , María Ángeles Vaz Salgado , Elena Vicente , Carlos Mesia Barroso , Angel Rodriguez Sanchez , Gema Durán , Ramon De Las Penas , José Muñoz-Langa , Guillermo de Velasco , Aurelio Hernandez-Lain , Amaya Hilario , L Miguel Navarro , Manuel Benavides , Laura Oleaga , Diana Cantero , Yolanda Ruano , Pilar Sanchez-Gomez , Estela Pineda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Central Nervous System Tumors

Track

Central Nervous System Tumors

Sub Track

Central Nervous System Tumors

Clinical Trial Registration Number

NCT02530320

Citation

J Clin Oncol 37, 2019 (suppl; abstr 2038)

DOI

10.1200/JCO.2019.37.15_suppl.2038

Abstract #

2038

Poster Bd #

227

Abstract Disclosures

Similar Posters

First Author: Theodore Willis Laetsch

First Author: Stephen Joseph Bagley